Ipilimumab
17G.508
Phase 1 mab terminated
Quick answer
Ipilimumab for Stage III Prostate Cancer is a Phase 1 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Stage III Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated